Evidence map›Paper›PMID 35995846›Full record

ArticleCell death and differentiation2023

SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma.

Qianping Chen, Wang Zheng, Jian Guan, Hongxia Liu, Yao Dan, Lin Zhu, Yimeng Song, Yuchuan Zhou, Xinrui Zhao, Yuhong Zhang and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 219 papers.

0numbers the graph read from it
0cells of the map it votes in
219citing papers in PubMed
40.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

219 citing papers in PubMed, 279 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Ferroptosis in cancer: molecular mechanisms, biological roles, and therapeutic significance.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  5. The emerging roles of disulfidptosis in cancer.Apoptosis : an international journal on programmed cell death · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

159 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Qianping Chen *Institute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Wang Zheng *Institute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Jian Guan *Department of Radiation Oncology, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, 510515, China.
Hongxia LiuInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Yao DanInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Lin ZhuDepartment of Radiation Oncology, Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Yimeng SongInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Yuchuan ZhouInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Xinrui ZhaoInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Yuhong ZhangInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Yang BaiInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Yan PanInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China. Swallowpan@fudan.edu.cn.ORCID 0000-0003-4307-3616
Jianghong ZhangInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China. zjh551268@fudan.edu.cn.ORCID 0000-0003-4884-6411
Chunlin ShaoInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China. clshao@shmu.edu.cn.ORCID 0000-0001-9336-9912
Shanghai Medical College of Fudan University · CNFudan University Shanghai Cancer Center · CNNanfang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radioresistance is a principal culprit for the failure of radiotherapy in hepatocellular carcinoma (HCC). Insights on the regulation genes of radioresistance and underlying mechanisms in HCC are awaiting for profound investigation. In this study, the suppressor of cytokine signaling 2 (SOCS2) were screened out by RNA-seq and bioinformatics analyses as a potential prognosis predictor of HCC radiotherapy and then were determined to promote radiosensitivity in HCC both in vivo or in vitro. Meanwhile, the measurements of ferroptosis negative regulatory proteins of solute carrier family 7 member 11 (SLC7A11) and glutathione peroxidase 4 (GPX4), intracellular lipid peroxidation and Fe

Indexed as

Carcinoma, HepatocellularFerroptosisLiver NeoplasmsAmino Acid Transport System y+ElonginHumansSuppressor of Cytokine Signaling ProteinsUbiquitinationUbiquitinsAmino Acid Transport System y+ElonginSLC7A11 protein, humanSOCS2 protein, humanSuppressor of Cytokine Signaling ProteinsUbiquitins

Identifiers

PMID35995846
PMCPMC9883449
OpenAlexW4292656960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.